IN MPJE key terms

The state agency that licenses pharmacists, technicians, interns, and pharmacies in Minnesota, adopts rules, and investigates and adjudicates complaints alleging violations of the Pharmacy Practice Act.

The credential issued by the Board that authorizes a person to practice pharmacy in Minnesota, obtained after education, examination, and background requirements are satisfied and renewed on the Board's cycle.

The Board credential that allows a person to perform technician duties under pharmacist supervision in Minnesota, typically requiring a Board application, fee, and compliance with training or certification requirements set by rule.

A student or graduate in a Board-approved pharmacy program who registers with the Board to gain supervised practical experience counting toward licensure, practicing only under a supervising pharmacist's direction.

The credential the Board issues to a physical location authorizing it to dispense drugs, contingent on meeting facility, security, equipment, and personnel standards and designating a pharmacist-in-charge.

A Board credential required for a pharmacy located outside Minnesota that ships, mails, or delivers dispensed prescription drugs to Minnesota patients, subjecting it to Minnesota dispensing and recordkeeping rules.

The number and type of credit hours a Minnesota licensee must complete each renewal cycle, including any mandated topics, with records retained and subject to Board audit.

A classification of drugs under federal and Minnesota law based on abuse potential and accepted medical use, ranging from Schedule I (no accepted medical use) to Schedule V (lowest abuse potential), which drives prescribing, dispensing, and recordkeeping rules.

The DEA registration number that authorizes a practitioner or pharmacy to handle controlled substances; Minnesota pharmacies and prescribers need it in addition to state authority and must renew it periodically.

The state statutory schedules that mirror and may add to federal scheduling, so a substance's Minnesota status can be stricter than its federal status; dispensers must apply the more restrictive applicable rule.

Minnesota's electronic database of dispensed controlled substances that prescribers and pharmacists must query in specified situations and report to, used to identify risky use patterns and doctor shopping.

The required timeframe after dispensing a controlled substance within which the pharmacy must submit dispensing data to the state monitoring program, including patient, drug, quantity, and prescriber identifiers.

A written authorization letting a designated agent of a registered pharmacy order Schedule II drugs from a distributor on the registrant's behalf, with the document retained for inspection.

An ongoing running record of controlled substances received and dispensed that lets a pharmacy reconcile expected against actual stock and detect diversion or recordkeeping gaps.

The complete count of all controlled substances on hand that a registrant must take every two years, retaining the dated record in a readily retrievable form for DEA and Board inspection.

The obligation to notify DEA and the Board in writing when controlled substances are discovered missing, describing the circumstances and quantity, and to report the matter promptly rather than waiting for an audit.

The period for which a pharmacy must keep prescriptions, inventory records, and other required documents in a retrievable form and available for inspection; Minnesota and federal periods differ by record type.

The original written or printed prescription document that a pharmacy must file and retain, subject to rules on annotations, refill documentation, and electronic alternatives.

An order for a drug issued by a practitioner with lawful prescribing authority that contains all required elements, is issued for a legitimate medical purpose, and is not obtained by fraud or forgery.

The pharmacist's independent duty to resolve red flags and refuse to fill a controlled substance prescription the pharmacist knows or should know is not for a legitimate medical purpose or lacks valid prescriber authority.

The documented process of investigating warning signs such as early refills, distant prescribers, cash payment, or overlapping opioid and benzodiazepine therapy, including contacting the prescriber and checking the PMP before dispensing.

The remaining number of times a prescription may be dispensed as authorized by the prescriber, with Schedule II limits, Schedule III-V caps, and expiration rules differing by schedule and state law.

The process of moving an unfilled or partially filled prescription between pharmacies, with requirements for direct communication, documentation of the transferring pharmacist and pharmacy, and restrictions on controlled substances.

Substituting a different drug within the same therapeutic class under a Board-approved protocol or prescriber authorization, distinct from generic substitution, and requiring notification and documentation.

Dispensing a therapeutically equivalent lower-cost product in place of the prescribed brand unless the prescriber prohibits it, with the patient informed and the substitution documented on the prescription record.

The pharmacist's discussion with the patient or caregiver about proper use, storage, interactions, and expected effects of a medication, which may be declined and must be offered and documented as required.

Transmitting a prescription electronically through a compliant system with prescriber authentication and required data elements, subject to exceptions and rules on controlled substances and pharmacy receipt.

The limits and conditions the Board sets on how many technicians or interns a pharmacist may supervise and what tasks require direct pharmacist oversight versus general supervision.

The pharmacist's assignment of a specific task to a technician or intern, which does not transfer the pharmacist's accountability for the outcome or the duty to verify the final product.

The pharmacist's review confirming that the correct drug, strength, dosage form, labeling, and directions were dispensed for the patient before the product leaves the pharmacy.

A written arrangement between a pharmacist and prescriber defining the drugs, conditions, and protocols the pharmacist may manage, including initiation, adjustment, and monitoring under agreed criteria.

The conditions under which a Minnesota pharmacist may administer vaccines, including training, certification, patient age limits, reporting to the state immunization system, and protocol or prescription requirements.

The authority allowing pharmacists to dispense or prescribe naloxone without a patient-specific prescription under state law, with instructions to the recipient and documentation of the encounter.

A preventable event involving inappropriate medication use, such as wrong drug, dose, route, or patient, that reaches or could reach the patient and should be documented and analyzed for system causes.

A pharmacy's systematic process for collecting error and near-miss data, identifying root causes, implementing changes, and measuring whether those changes reduced future risk.

An ongoing cycle of measuring performance, testing changes, and standardizing improvements in dispensing and counseling, with the goal of reducing harm rather than assigning individual blame.

The requirements for preparing customized medications, including facility and equipment controls, personnel training, master formulation records, beyond-use dating, and quality testing based on risk level.

The statutory list of conduct that can lead to Board action, such as practicing beyond scope, dispensing without a valid prescription, impairment, fraud, or failing to meet recordkeeping and supervision duties.

Behavior that violates accepted standards of pharmacy practice or undermines public trust, including dishonesty, breaching patient confidentiality, and practicing while impaired, and which can independently support discipline.

The Board's process of gathering records, interviewing witnesses, and reviewing a complaint, followed by possible dismissal, corrective action, or formal disciplinary charges with an opportunity to respond.

The procedural protections a licensee receives in a Board matter, including notice of the allegations, a meaningful opportunity to respond with evidence, and a fair decision-maker.

A non-disciplinary or lesser Board resolution such as a citation, fine, education requirement, or practice restriction used to address a violation without revoking or suspending the license.